Skip to main content

Table 2 Baseline characteristics for patients with and without subcutaneous tophi a

From: Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy

Demographics

Patients with

Patients without

 

baseline tophi

baseline tophi

(n= 155)

(n= 57)

Males, n (%)

126 (82)

47 (81)

Whites, n (%)

106 (68)

37 (65)

Mean age, years (±SD)

56.7 (13.7)

51.9 (14.4)

Mean BMI, kg/m2 (±SD)

31.3 (6.6)

36.7 (8.6)

Mean baseline PUA, mg/dl (±SD)

9.8 (2.9)

9.4 (3.3)

  1. aBMI, body mass index; PUA, plasma uric acid.